What are the stages of tricuspid regurgitation (TR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Staging of Tricuspid Regurgitation

The 2014 AHA/ACC guidelines establish a four-stage classification system (A through D) for tricuspid regurgitation that progresses from patients at risk through symptomatic severe disease, guiding both surveillance and intervention timing. 1

Stage A: At Risk of TR

Patients have risk factors for TR but no or only trace regurgitation present. 1

Primary TR Risk Factors:

  • Mild rheumatic valve changes 1
  • Mild leaflet prolapse 1
  • Infective endocarditis with vegetation 1
  • Early carcinoid deposition 1
  • Radiation exposure 1
  • Intra-annular RV pacemaker or ICD leads 1
  • Post-cardiac transplant (biopsy-related damage) 1

Functional TR Risk Factors:

  • Normal valve anatomy with early annular dilation 1
  • No hemodynamic consequences or symptoms at this stage 1

Stage B: Progressive TR

Patients have mild-to-moderate TR with early structural changes but remain asymptomatic. 1

Valve Anatomy:

Primary TR:

  • Progressive leaflet deterioration or destruction 1
  • Moderate-to-severe prolapse with limited chordal rupture 1

Functional TR:

  • Early annular dilation 1
  • Moderate leaflet tethering 1

Hemodynamic Parameters:

Mild TR:

  • Central jet area <5.0 cm² 1
  • Soft, parabolic continuous wave (CW) jet density and contour 1
  • Hepatic vein flow shows systolic dominance 1

Moderate TR:

  • Central jet area 5-10 cm² 1
  • Vena contracta width <0.70 cm 1
  • Dense CW jet with variable contour 1
  • Hepatic vein flow shows systolic blunting 1

Hemodynamic Consequences:

  • RV/RA/IVC size remains normal 1
  • No RV enlargement 1
  • No or mild RA enlargement 1
  • Normal RA pressure 1

Stage C: Asymptomatic Severe TR

Patients have severe TR by echocardiographic criteria but no symptoms attributable to right heart failure. 1

Valve Anatomy:

Primary TR:

  • Flail or grossly distorted leaflets 1

Functional TR:

  • Severe annular dilation (>40 mm or >21 mm/m²) 1
  • Marked leaflet tethering 1

Hemodynamic Parameters:

  • Central jet area >10.0 cm² 1
  • Vena contracta width >0.7 cm 1
  • Dense, triangular CW jet with early peak 1
  • Hepatic vein flow shows systolic reversal 1

Hemodynamic Consequences:

  • RV/RA/IVC dilated 1
  • Decreased IVC respirophasic variation 1
  • Elevated RA pressure with prominent "c-V" waves 1

Stage D: Symptomatic Severe TR

Patients have severe TR with symptoms of right heart failure, representing the most advanced stage requiring intervention. 1

Valve Anatomy and Hemodynamics:

  • Identical echocardiographic criteria to Stage C (central jet area >10.0 cm², vena contracta >0.7 cm, systolic flow reversal in hepatic veins) 1
  • RV/RA/IVC dilation with decreased IVC respirophasic variation 1

Cardinal Symptoms:

  • Fatigue and reduced exercise capacity 1, 2
  • Palpitations (particularly with atrial fibrillation, present in 70-88% of severe TR patients) 2
  • Dyspnea with exertion or at rest 1, 2
  • Abdominal bloating and fullness from hepatic congestion 1, 2
  • Anorexia from splanchnic congestion 1, 2
  • Peripheral edema 1, 2

Critical Clinical Point:

Patients with signs or symptoms of right heart failure are classified as Stage D even if they do not meet all other hemodynamic or morphological criteria for severe TR. 1

Clinical Implications by Stage

Surveillance:

  • Stage A: Monitor for progression of risk factors 1
  • Stage B: Serial echocardiography to assess progression 1
  • Stage C: Close monitoring with consideration for intervention timing 1
  • Stage D: Urgent surgical evaluation indicated 1, 3

Intervention Timing:

Tricuspid valve surgery is recommended (Class I) for patients with severe TR (Stage D) at the time of left-sided valve surgery. 1, 3

Concomitant tricuspid repair should be considered when tricuspid annular diameter is ≥40 mm (or ≥21 mm/m²) at the time of left-sided valve surgery, as TR often persists or progresses even after successful treatment of left-sided lesions. 4

Common Pitfalls

  • Do not rely solely on murmur presence: A systolic murmur may be inaudible even with severe TR; elevated jugular venous pressure with prominent "c-V" waves may be the only clinical clue. 1, 2

  • Do not delay surgical referral in Stage D: Severe TR is associated with poor prognosis independent of age, LV and RV function, and RV size, with heart failure being the most common cause of death (50%). 1, 5

  • Do not underestimate functional TR: Approximately 80% of significant TR is functional in nature, related to tricuspid annular dilation and leaflet tethering from RV remodeling. 1

  • Recognize that the tricuspid annulus often does not return to normal size after relief of RV overload: The annulus becomes planar and circular as it dilates, losing its normal saddle-shaped configuration. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tricuspid Regurgitation Symptoms and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Symptomatic Relief of Severe Tricuspid Regurgitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Etiology of Moderate Tricuspid Regurgitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impact of severe tricuspid regurgitation on long term survival.

Research in cardiovascular medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.